GGrantIndex
← Search

PHASE I/II TRIAL OF SUBCUTANEOUS CALCITRIOL AND PREDNISONE IN ADVANCED CANCER

$3,034M01FY2000RRNIH

University Of Pittsburgh At Pittsburgh, Pittsburgh PA

Investigators

Linked publications & trials

Abstract

The premise of this study is to conduct a Phase I/II study to evaluate the combined approach of calcitrol and prednisone in patients with advanced cancer. Vitamin D is a steroid hormone best known for its activity in regulating calcium and bone metabolism. The active form of vitamin D is calcitriol [1,25-(OH) 2D3]. Epidemiologic evidence suggests that calcitriol may play an important role in the development of colon and prostate cancer. Preclinical studies of cancer cell lines have shown that calcitriol can kill tumor cells.

View original record on NIH RePORTER →